An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary

Woo Kon Jeong1, Myung Ho Jeong, Kye Hun Kim

  • 1Cardiac Catheterization Laboratory, Heart Center of Chonnam National University Hospital, Hakdong 8, Dong-gu, Gwangju, 501-757, Korea.

Insights

C-reactive protein (CRP) levels are a key indicator for restenosis after percutaneous coronary interventions (PCI). Elevated CRP significantly predicts restenosis, highlighting its importance in cardiovascular disease management.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation

Background:

  • Percutaneous coronary interventions (PCI) are limited by restenosis.
  • Inflammation is implicated in cardiovascular disease pathogenesis.

Purpose of the Study:

  • To prospectively evaluate inflammatory markers as predictors of restenosis after PCI.
  • To compare seropositivity and C-reactive protein (CRP) levels in patients with and without restenosis.

Main Methods:

  • 272 patients with coronary artery disease undergoing PCI were studied.
  • Patients were divided into groups based on restenosis occurrence.
  • IgG seropositivity, CMV titers, C. pneumoniae, H. pylori, and CRP levels were compared.

Main Results:

  • No significant differences in IgG seropositivity for CMV, C. pneumoniae, or H. pylori were found.
  • Low Thrombolysis in Myocardial Infarction (TIMI) flow was more common in the restenosis group.
  • Elevated CRP levels (> 0.5 mg/dL) and higher CRP values were significantly associated with restenosis (p = 0.001).

Conclusions:

  • C-reactive protein (CRP) is the most significant predictor of restenosis following PCI.
  • Inflammatory marker assessment, particularly CRP, is crucial for predicting PCI outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...